Benzodiazepines have come under scrutiny and attack over recent years becau
se of their abuse liability, withdrawal reactions and development of tolera
nce. Consequently, practitioners worldwide are discouraged from prescribing
them. While some of these risks may have been exaggerated, benzodiazepines
remain a useful therapeutic tool, alone or in combination, in a number of
psychiatric and medical conditions. Withholding such treatment may be unjus
tified and detrimental to the patients' health. Further, benzodiazepines ha
ve helped researchers in their attempts to elucidate the neurobiological me
chanisms underlying anxiety. This, in return, leads to the development of n
ew effective anxiolytic treatments, with fewer problems compared to the tra
ditional benzodiazepine compounds. Such new agents are already available or
at the closing stages of clinical trials. (C) 1999 Elsevier Science B.V. A
ll rights reserved.